Genocea Biosciences (GNCA)

P/S ratio on February 24, 2023 (TTM) : 38.4

According to Genocea Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.00307588. At the end of 2022 the company had a P/S ratio of 38.4.

P/S ratio history for Genocea Biosciences from 2014 to 2022

PS ratio at the end of each year

Year	P/S ratio	Change
2022	38.4	-5.39%
2021	40.6	-55.84%
2020	91.9
2019	N/A
2018	N/A
2017	N/A	-100%
2016	498	124.71%
2015	221	-45.42%
2014	406

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Agenus AGEN	0.8379	27,139.49%	🇺🇸 USA
Novavax NVAX	2.57	83,562.89%	🇺🇸 USA
Merck MRK	4.75	154,472.68%	🇺🇸 USA
iBio IBIO	331	10,750,774.55%	🇺🇸 USA
Pfizer PFE	3.00	97,358.94%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is receiving financial compensation for Delta App installs.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Genocea Biosciences (GNCA)

P/S ratio on February 24, 2023 (TTM) : 38.4